Navigation Links
Tepha Announces Appointment of John Hartnett as Executive Vice President and Chief Operating Officer
Date:7/24/2008

LEXINGTON, Mass., July 24 /PRNewswire/ -- Tepha, Inc., a developer of medical devices derived from a new class of resorbable polymers, announced today that it has appointed John Hartnett to the new position of Executive Vice President and Chief Operating Officer. Mr. Hartnett joins Tepha following an eighteen year career with Boston Scientific during which he progressed from field sales, to marketing management, and, most recently, to strategic planning and business development. Mr. Hartnett's responsibilities with Tepha will focus on corporate partner management and long range planning.

Dr. Simon Williams, President and CEO of Tepha, commented, "We are very excited to be able to attract an executive with John Hartnett's track record of success in the medical device industry. The unique profile of our resorbable polymer technology, combined with the receipt of six FDA 510(k)'s since February, 2007, has resulted in a significant increase in Tepha's corporate partner activities. Mr. Hartnett's strategic planning and business development experience will be extremely valuable as Tepha expands its corporate partnering business model."

About Tepha, Inc.

Tepha, Inc., is a developer of medical devices derived from a new class of resorbable polymers that have been engineered utilizing recombinant DNA technology. The unique biologic and mechanical properties of the Tepha PHA polymers has been recognized by an expanding list of corporate partners that now includes Aesculap AG, ENTrigue Surgical, HemCon Medical Technologies, the Lifecell subsidiary of Kinetic Concepts (NYSE: KCI), NMT Medical (Nasdaq: NMTI), and Tornier, Inc. Tepha received its first FDA 510(k) clearance for its TephaFLEX(R) Absorbable Suture in February, 2007 and the Company and its partners have now received six 510(k)'s covering a range of medical devices including sutures, meshes, and films.

For further information about Tepha, please contact Dr. Ajay Ahuja, M.D., Director of Business Development, Tepha, Inc., 99 Hayden Ave, Lexington, MA 02421, tel: 781-357-1700. Email: contact@tepha.com. Or visit: http://www.tepha.com


'/>"/>
SOURCE Tepha, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Carnegie Mellon Establishes Ray and Stephanie Lane Center for Computational Biology
2. BD Announces Results for Third Fiscal Quarter
3. Gerbig Engineering Announces Availability of Cleanroom Utility Panel
4. The Palomino Group Announces Launch of Meeting Support Services Business Unit
5. Misys Announces Preliminary Results for the Year Ended 31 May 2008
6. Cardiome Announces Preferred Share Financing
7. Mercy Health Plans Announces New Name for Their Medicare Advantage Plans: Mercy Medicare Advantage
8. American Heart Associations Announces Call for Entries for Howard L. Lewis Achievement Award
9. The Risk Management and Patient Safety Institute Announces 2008/2009 Annual Risk Management Conference, Dates
10. Genesis Pharmaceuticals Announces New Board Member and Forms Committees
11. Fitness Equipment Retailer Fitness 4 Home Superstore Announces New Scottsdale Location
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
(Date:6/24/2016)... MD (PRWEB) , ... June 24, 2016 , ... ... protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect ... G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 /PRNewswire/ ... Diabetes Tomorrow,s Leaders Scholarship is any indication, the future ... today online at www.diabetesscholars.org by the Diabetes ... stand in the way of academic and community service ... scholarship program since 2012, and continues to advocate for ...
Breaking Medicine Technology: